Literature DB >> 71974

Flurbiprofen at night.

E C Huskisson, P J Scott, S Boyle, M Patrick.   

Abstract

Three double-blind crossover trials were used to study the effects of single doses of flurbiprofen at night on pain at night, duration of morning stiffness and sleep disturbance in patients with active rheumatoid arthritis. Flurbiprofen (150 mg) was shown to be superior to placebo and 150 mg was no more effective than 100 mg. Serum levels of the drug were significantly higher with 150 mg but did not correlate with clinical effects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71974     DOI: 10.1185/03007997709108982

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

Review 1.  Correlation plasma levels, NSAID and therapeutic response.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

2.  Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.

Authors:  I C Kowanko; R Pownall; M S Knapp; A J Swannell; P G Mahoney
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

3.  Flurbiprofen concentration in soft tissues is higher after topical application than after oral administration.

Authors:  Shuken Kai; Eiji Kondo; Yasuyuki Kawaguchi; Nobuto Kitamura; Kazunori Yasuda
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 4.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 5.  Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.